Since Maze Therapeutics was founded in 2019, it has participated in 6 rounds of funding. In total Maze Therapeutics has raised $731.0M. Maze Therapeutics' last funding round was on Sep 2025 for a total of $150.0M.
Maze Therapeutics has 25 investors, including Frazier Life Sciences, Deep Track Capital and Janus Henderson Investors. The latest investment occurred in Sep 2025.
